Carrie Marguet, NP
Adult Health · Greenville, SCNPI 1538248737
Payments from drug & device makers
Across 68 payments — averaging $23.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$226
- AbbVie$196
- Johnson & Johnson$136
- Merck$118
- Bayer$106
- Novartis$105
- plus $734 from 19 others
What the payments were for
- Food & beverage$1,57197%
- Education$503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead(2 entities) | 8 | $226 |
| AbbVie | 9 | $196 |
| Johnson & Johnson | 6 | $136 |
| Merck | 4 | $118 |
| Bayer | 4 | $106 |
| Novartis | 4 | $105 |
| Incyte Corporation | 4 | $104 |
| Daiichi Sankyo Inc. | 4 | $94 |
| Seagen Inc. | 4 | $79 |
| AstraZeneca(2 entities) | 3 | $69 |
| Pfizer | 2 | $52 |
| Eisai Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Stemline Therapeutics Inc. | 1 | $30 |
| Taiho Oncology, Inc. | 1 | $29 |
| Sobi, Inc | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Acrotech Biopharma Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| G1 Therapeutics, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Inari Medical, Inc. | 1 | $13 |
How this compares
$1,620 in reported general payments places this provider in the 60th percentile of 292 adult health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 15 | $185 |
| Ondansetron Hcl | 15 | $159 |
| Promethazine Hcl | 16 | $130 |
| Gabapentin | 12 | $123 |
| Anastrozole | 11 | $86 |
| Levofloxacin | 13 | $74 |
Paid to pharmacies, not to this prescriber.
Other adult health in Greenville
- Karen RobertsonGreenville$69K
- Jessica RiceGreenville$15K
- Sheri MorrisGreenville$8K
- James McKenzieGreenville$8K
- Gary SzetoGreenville$6K
- John SharkeyGreenville$6K
- Sarah BaranskiGreenville$5K
- Brandi RuffoGreenville$4K
- Lynn CurryGreenville$4K
- Christine FranzeseTega Cay$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.